683 Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-49,564
Closed -$300K 354
2022
Q1
$300K Hold
49,564
0.02% 238
2021
Q4
$418K Buy
+49,564
New +$433K 0.02% 223

Other funds holding APEN

683 Capital Management's APEN Position: Q2 2022 in Review

683 Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2022, closing a stake of 49,564 shares — an estimated $300K sold.

683 Capital Management first reported a position in APEN in Q4 2021 and held it in 2 quarters. The position peaked at $418K in Q4 2021. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.

  • 683 Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2022 after selling out during the quarter.
  • 683 Capital Management sold 49,564 Apollo Endosurgery, Inc. shares in Q2 2022, an estimated $300K.
  • 683 Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 2 quarters.
  • 683 Capital Management's Apollo Endosurgery, Inc. position peaked at $418K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2022.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.